Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Crispr Therapeutics AG (1CG) vs. Competitors

2 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CH:1CGCrispr Therapeutics AGCHF 39.80CHF 3.44B-8.91-11.66%Moderate BuyUnlock the CH:1CG analyst price target with TipRanks PremiumCH:1CGUnlock the CH:1CG top-analyst price target with TipRanks Premium
NTLAIntellia Therapeutics$9.70$1.36B-2.9011.88%HoldUnlock the NTLA analyst price target with TipRanks PremiumCH:1CG vs NTLAUnlock the NTLA top-analyst price target with TipRanks Premium
BEAMBeam Therapeutics$22.83$2.36B-22.835.40%Strong BuyUnlock the BEAM analyst price target with TipRanks PremiumCH:1CG vs BEAMUnlock the BEAM top-analyst price target with TipRanks Premium
LEGNLegend Biotech$17.50$3.39B-1750.00-43.57%Moderate BuyUnlock the LEGN analyst price target with TipRanks PremiumCH:1CG vs LEGNUnlock the LEGN top-analyst price target with TipRanks Premium
KYMRKymera Therapeutics$127.57$10.89B-35.14100.49%Strong BuyUnlock the KYMR analyst price target with TipRanks PremiumCH:1CG vs KYMRUnlock the KYMR top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CH:1CGCrispr Therapeutics AG39.80-5.25-11.66%
NTLAIntellia Therapeutics9.701.2214.39%
BEAMBeam Therapeutics22.830.813.68%
LEGNLegend Biotech17.50-12.22-41.12%
KYMRKymera Therapeutics127.5763.4799.02%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts